Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack D Burton

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Methods in Molecular Medicine|May 20, 2005
The MTT assay to evaluate chemosensitivityJack D Burton
Expert Opinion on Emerging Drugs|September 11, 2010
New agents and approaches to the treatment of B-cell non-Hodgkin lymphomaJack D Burton, David M Goldenberg
PPAR Research|September 10, 2008
Potential of peroxisome proliferator-activated receptor gamma antagonist compounds as therapeutic agents for a wide range of cancer typesJack D Burton, David M Goldenberg, Rosalyn D Blumenthal
Anti-Cancer Drugs|April 7, 2007
Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell linesJack D Burton, Mary E Castillo, David M Goldenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
CD74 is expressed by multiple myeloma and is a promising target for therapyJack D Burton, Scott Ely, Praveen K Reddy, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Methods in Molecular Medicine|May 20, 2005
The MTT assay to evaluate chemosensitivityJack D Burton
Expert Opinion on Emerging Drugs|September 11, 2010
New agents and approaches to the treatment of B-cell non-Hodgkin lymphomaJack D Burton, David M Goldenberg
PPAR Research|September 10, 2008
Potential of peroxisome proliferator-activated receptor gamma antagonist compounds as therapeutic agents for a wide range of cancer typesJack D Burton, David M Goldenberg, Rosalyn D Blumenthal
Anti-Cancer Drugs|April 7, 2007
Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell linesJack D Burton, Mary E Castillo, David M Goldenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
CD74 is expressed by multiple myeloma and is a promising target for therapyJack D Burton, Scott Ely, Praveen K Reddy, et al.
Pageof 1